Compass Therapeutics, Inc.
CMPX
$1.78
$0.031.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -43.46% | 19.86% | -21.22% | 19.59% | -34.63% |
| Total Depreciation and Amortization | -22.80% | -0.21% | 0.65% | -1.07% | 0.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.50% | 37.73% | -14.32% | 106.47% | -6.08% |
| Change in Net Operating Assets | 219.85% | -740.04% | 108.90% | -2,562.05% | -107.12% |
| Cash from Operations | 17.09% | -2.76% | 22.57% | -12.42% | -108.61% |
| Capital Expenditure | 100.00% | -- | -- | -- | 10.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.11% | 348.28% | 258.16% | -164.83% | -62.93% |
| Cash from Investing | -47.03% | 347.60% | 258.16% | -164.92% | -62.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | 100.00% | 14.47% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -300.00% | 100.18% | -54,500.00% | -- |
| Cash from Financing | -4,600.00% | -300.00% | -99.99% | 11,133.54% | -852.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.97% | 520.73% | -670.76% | 91.06% | -155.60% |